Register for free to listen to this article
Listen with Speechify
0:00
2:00
MENLO PARK, Calif.—DNA2.0 last month announced acollaboration with Newcastle University to develop a protein expression systemfor Bacillus subtillis, with DNA2.0'sGeneGPS gene optimization technology serving as the basis for the developmentof enhanced gene synthesis algorithms for the bacterium.
 
 
The system will further the work of NewCastle Centre forBacterial Cell Biology and School of Computing Science Prof. Anil Wipat on thesynthetic biology applications of B. subtillis, the chief production host for industrial enzyme manufacturing and adominant bacterial workhorse for microbial fermentations.
 
 
Industrial applications include production of amylases,proteases, inosine, ribosides and amino acids. The organism, which isconsidered safe for humans, is also key to the production of soya-based nattoproduction in Japan. The understanding of the molecular biology and physiologyof this important gram-positive model organism is second only to Escherichiacoli. This makes B. subtillis an ideal host for industrial synthetic biology.
 
 
"Professor Wipat's lab at Newcastle is producing some of themost important research in synthetic biology today, and we are excited to becollaborating with him," said Dr. Jeremy Minshull, cofounder and CEO of DNA2.0,in a press release. "By combining our patented GeneGPS technology—which hasbeen proven to increase protein expression up to 100-fold—with Newcastle's deepexperience with B. subtillis, I'mconfident that we will develop a best-in-class solution for this importantbacterium for industrial biotechnology."
 
 
In addition to developing a robust expression system for B.subtillis, the two organizations expect that the gene design algorithms thatthey develop will be likely to mimic related gram positives that are also verypopular in industrial biotechnology. Industrially important organisms such as Clostridium,Lactobacillus and Geobacillus share similarities with B. subtilis in their development and genetics. As a result, theknowledge gained from optimizing expression for this organism promises to bemore widely applicable in an industrial context, according to the partners.

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue